Paul Tudor Jones’s Assembly Biosciences ASMB Stock Holding History

Paul Tudor Jones’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,979	Closed	-$314K	–	1484
2015 Q1	$314K	Buy	+1,979	New	+$268K	0.01%	1021

Other funds holding ASMB

Jennison Associates

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Paul Tudor Jones's ASMB Position: Q2 2015 in Review

Paul Tudor Jones sold out of Assembly Biosciences (ASMB) in Q2 2015, closing a stake of 1,979 shares — an estimated $314K sold.

Paul Tudor Jones first reported a position in ASMB in Q1 2015 and held it in 1 quarter. The position peaked at $314K in Q1 2015. 57 funds tracked by Wall St. Rank hold ASMB as of Q2 2015.

Paul Tudor Jones reported no remaining Assembly Biosciences position as of Q2 2015 after selling out during the quarter.
Paul Tudor Jones sold 1,979 Assembly Biosciences shares in Q2 2015, an estimated $314K.
Paul Tudor Jones first reported a position in Assembly Biosciences in Q1 2015 and held it in 1 quarter.
Paul Tudor Jones's Assembly Biosciences position peaked at $314K in Q1 2015.
57 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2015.

Based on Tudor Investment Corp's 13F filing for Q2 2015, filed 14 Aug 2015.